Latest Staar Surgical Company (STAA) Headlines
Post# of 36
Posted On: 03/13/2014 2:55:29 AM
Latest Staar Surgical Company (STAA) Headlines
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
IPOs and Transactions: February 24 - 28
PR Newswire - Tue Mar 04, 10:35AM CST
There were 45 transactions filed with the SEC last week.
Visian® ICL(TM) with CentraFLOW® Approved to Market in Japan
PR Newswire - Mon Mar 03, 8:14AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Visian Implantable Collamer Lens with CentraFLOW technology, which is driven by the KS-AquaPORT, has been approved by the Japanese Ministry of Health, Labor and Welfare. With this approval, the range of treatment has been expanded for Visian ICL product offering to include not only the CentraFLOW technology, but also expands the treatment of myopic down to -3.0 diopters as compared to the current range which starts at -5.0 diopters.
STAAR Surgical Reports 15% Fourth Quarter Revenue Growth and 13% Full Year 2013
PR Newswire - Wed Feb 26, 3:01PM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported revenue for the fourth quarter ended January 3, 2014 of $18.9 million, a 15% increase over $16.5 million reported for the fourth quarter of 2012. The effect of foreign currency exchange reduced sales by $1.1 million during the quarter. On a constant currency basis, revenues grew 22% during the fourth quarter of 2013 compared to the fourth quarter of 2012. The results included record quarterly sales of $11.5 million of the Company's Visian® ICL product portfolio and $6.6 million of its IOL products. Low margin Other Product sales were $812,000, a 12% decrease over the prior year and a 3% decrease in constant currency.
Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 25, 5:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/qppn9j/contact_lens) has announced the addition of the "Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Contact Lens Market (Gas Permeable Contact Lens and Soft Contact Lens) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' Contact lens are medical devices that offer convenience, confidence and self-esteem to the people who need vision correction. Factors such as rising ophthalmic disorders, vision problem and changing lifestyle accentuates the uptake of contact lenses during the forecast period. In addition, therapeutic, aesthetic and cosmetic are the major reasons driving the growth of contact lens market globally. The market for contact lens is segmented as by characteristics (gas-permeable and soft contact lens), by design (spherical, toric, soft, multifocal, cosmetic and orthokeratology contact lens) and by usage (corrective, therapeutic, post-operative, cosmetic, enhancement, opaque and special effect, prosthetic, computer, D-segment, sports and custom-made). The report includes market estimations of the global contact lens market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contact lens market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019. The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the contact lens market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Contact Lens Market, by Characteristics Chapter 5 Contact Lens Market, by Design Chapter 6 Contact Lens Market, by Usage Chapter 7 Contact Lens Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles List of Figures List of Tables Companies Mentioned - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/qp...ntact_lens About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
STAAR Surgical To Present At The 34th Annual Cowen Health Care Conference
PR Newswire - Mon Feb 24, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 34th Annual Cowen Health Care Conference at the Boston Marriott Copley Place Hotel on Monday, March 3 at 4:50 p.m. ET.
STAAR Surgical Announces Fourth Quarter 2013 Results Release Date, Conference Call And Webcast
PR Newswire - Fri Feb 14, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release its financial results for the fourth quarter ended January 3, 2014 on Wednesday, February 26, 2014 after the market close.
ReneSola Supplies Several Million Watts of Solar PV to Chevron
PR Newswire - Fri Feb 14, 3:00AM CST
ReneSola Ltd ("ReneSola") (NYSE: SOL), a leading brand and technology provider of solar photovoltaic ("PV") products, announced today that it provided 10,000 of its high efficiency solar PV modules to Chevron Energy Solutions, one of the largest installers of solar power in the United States, for a 3.1MW multi-site project in Lemoore, California. The multi-array project will consist of 2.85MW of ReneSola's 72-cell 300W polycrystalline modules and 260KW of 260W monocrystalline modules.
VMS Ventures Announces Annual Meeting, Record Date and Adopts Advance Notice Policy
Marketwire Canada - Thu Feb 13, 9:31AM CST
VMS Ventures Inc. (TSX VENTURE:VMS) ("VMS Ventures" or the "Company") announced on February 13, 2014 that it will hold an annual meeting of shareholders (the "Meeting") on April 17, 2014. The record date for the shareholders entitled to vote at the Meeting has been set as shareholders of record as at the close of business on March 10, 2014.
FDA Postpones Meeting To Review Staar Surgical's TICL Submission Due To Weather
PR Newswire - Thu Feb 13, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported the U.S. Food & Drug Administration's Ophthalmic Devices Panel of the Medical Devices Advisory Committee meeting scheduled for Friday, February 14, 2014 has been postponed due to weather. The Agency has assured the Company that it intends to reschedule the meeting as soon as practically possible. The meeting was being convened by the Agency to ask the Panel questions regarding STAAR's PMA supplement submission seeking approval to market the Company's Visian Toric Implantable Collamer® Lens. Any rescheduled date will be published by the FDA on its website.
Concise Analysis of the International Femtosecond Lasers for Cataract Surgery Market - Forecasts to 2018
M2 - Fri Jan 31, 4:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/p7nkbl/femtosecond) has announced the addition of a new report "Concise Analysis of the International Femtosecond Lasers for Cataract Surgery Market - Forecasts to 2018" to their offering. This femtosecond laser cataract surgical system equipment makes it possible to deliver reproducible, predictable, and improved clinical outcomes for cataract surgery. Through image-guided visualization and micron-level laser precision, the surgeon has complete control over the surgery process. Femtosecond laser cataract surgical systems offer an improved patient safety profile. Because of the simultaneous change in demographics and the introduction of automated process, ophthalmologists are facing an explosion in demand for their services the next 20 years. The aging of the baby boomers and the fact that patients older than 65 consume 10 times the eye care of patients younger than 65 creates unprecedented demand for cataract surgery. Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting. Cataract surgical technology is evolving rapidly. Laser-assisted cataract surgery technology is gaining traction with clinicians. Surgeons are getting trained in the techniques needed to perform surgeries using these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision. Key Topics Covered: Femtosecond Lasers for Cataract Surgery: Executive Summary 1. Femtosecond Lasers for Cataract Surgery: Market Shares and Market Forecasts 2. Femtosecond Lasers for Cataract Surgery 3. Cataract Surgery Femtosecond 4. Femtosecond Lasers for Cataract Surgery Technology 5. Femtosecond Laser for Cataract Companies Mentioned: - AISIN / IMRA Femtolite F / H - Abbott - Bioptigen - Biovision - Calmar Laser - Family - Market Participants - Novartis / Alcon - Novartis / Alcon - Ophtec Artisan R - OptiMedica - Raydiance 5-60 - Staar Surgical 5-66 - Valeant / Bausch & Lomb - WaveTec Vision - Zeiss For more information visit http://www.researchandmarkets.com/research/p7...emtosecond
Align Technology Announces ClinCheck(R) Pro With Interactive 3D Controls
Marketwire - Thu Jan 30, 3:00PM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced the upcoming release of ClinCheck Pro, the next generation Invisalign treatment software tool, designed to provide more precise control over final tooth position and to help Invisalign providers achieve their treatment goals.
Kathryn Tunstall Appointed To STAAR Surgical Board Of Directors
PR Newswire - Thu Jan 30, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the appointment of Kathryn Tunstall to its Board of Directors. Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a developer, maker, and marketer of medical devices for women. In 2013 Conceptus was acquired by Bayer AG for $1.1 billion. Her appointment expands the number of directors to seven.
STAAR Surgical Company (STAA) Jumps: Stock Up 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 8:39AM CST
STAAR Surgical Company was a big mover last session, as its shares rose almost 6% on the day.
2013 Report on the International Surgical Ophthalmology Market
M2 - Fri Dec 13, 3:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/t7rpn5/global_markets) has announced the addition of the "2013 Report on the International Surgical Ophthalmology Market" report to their offering. Refractive surgeries will also contribute to revenue growth, although economic headwinds in key national markets will limit the performance of these procedures. Other key trends, including pricing in local markets and product mix, will have key effects on competitive shares and product adoption. Key Topics Covered: 1. EXECUTIVE SUMMARY 1.1 The Global Market by Region 1.2 The Global Market by Product Segment 2. OVERVIEW 2.1 Anatomy of the Human Eye 2.2 Blindness and Low Vision 2.3 Cataract Surgery 2.4 Glaucoma Surgery 2.5 Vitreoretinal Surgery 2.6 Refractive Surgery 3. OPHTHALMIC DIAGNOSTIC DEVICES 3.1 Slit Lamps 3.2 Ocular Tonometers 3.3 Corneal Pachymeters 3.4 Optical Coherence Tomography 3.5 Optical Biometers 3.6 Scanning Laser Polarimeters 3.7 Fundus Cameras 3.8 Wavefront Aberrometers 4. OPHTHALMIC SURGICAL SYSTEMS 4.1 Phacoemulsification Systems 4.2 Ophthalmic Laser Systems 5. IMPLANTS AND DISPOSABLES 5.1 Intraocular Lenses 5.2 Glaucoma Implants 6. PROCEDURE VOLUMES AND MARKET FORECASTS 6.1 Global Procedure Volumes 6.2 Global Market Analysis 6.3 Competitive Analysis 6.4 Regional Analysis 7. COMPANY PROFILES Companies Mentioned: - Abbott Medical Optics - Accutome - Alcon - Bausch & Lomb - Carl Zeiss Meditec - Dutch Ophthalmic Research Center (DORC) International BV - Ellex - Haag-Streit AG - Iridex Corporation - LensAR - Lumenis Vision - Nidek Company, Ltd. - Oertli Instruments AG - Ophtec BV - Optimedica - Quantel Medical - Staar Surgical - Technolas Perfect Vision - Topcon Medical Systems - Ziemer Ophthalmic Systems AG For more information visit http://www.researchandmarkets.com/research/t7...al_markets
STAAR Surgical Up 97.6% Since SmarTrend Uptrend Call (STAA)
Comtex SmarTrend(R) - Mon Dec 02, 9:09AM CST
SmarTrend identified an Uptrend for STAAR Surgical (NASDAQ:STAA) on January 2nd, 2013 at $6.33. In approximately 11 months, STAAR Surgical has returned 97.63% as of today's recent price of $12.51.
2013 Report on the International Intraocular Lenses Market
M2 - Fri Nov 29, 4:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/xz96c5/intraocular#summary) has announced the addition of the "2013 Report on the International Intraocular Lenses Market" report to their offering. Despite initial lethargy in adoption by surgeons, intraocular lens (IOL) implants are today standard treatment of care for cataract. Cataract surgeries using IOLs are currently one of the most common and safest surgical procedures carried out worldwide. With the rise in aging population and increase in the incidence of ophthalmic and ocular conditions, vision care represents a growing sector of the medical industry. Among the ocular diseases, cataract is the most common cause of blindness, followed by glaucoma, AMD and DR. The IOL market is also benefiting from the development of premium intraocular lenses, adoption of which is driven by factors such as superior visual outcomes, and long term safety, efficacy, and rotational stability. While improved access to superior medical technologies drives growth in developing countries, the continued shift towards premium IOLs including toric, accommodative and multifocal IOLs, is fuelling demand in developed countries. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview 3. Trends & Issues 4. Competition 5. Product Landscape 6. Product Overview 7. Effects Of Intraocular Lenses Implantations 8. Regulations Governing The Production And Approval Of Iols 9. Product Approvals/Introductions 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 36 (including Divisions/Subsidiaries - 48) - The United States (20) - Canada (1) - Japan (6) - Europe (14) - France (3) - Germany (5) - The United Kingdom (1) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (7) Companies Mentioned - Abbott Medical Optics - Bausch & Lomb - Carl Zeiss - Eyekon Medical - Humanoptics - Lenstec - Morcher GmbH - Novartis AG - Oculentis BV - Ophtec BV - Ophtec USA - Physio SA - PowerVision - Rayner Intraocular Lenses - Santen Pharmaceutical - Advanced Vision Science - Staar Surgical Company - Suzhou Medical Apparatus and Instrument - Tekia - US IOL - Wavelight AG For more information visit http://www.researchandmarkets.com/research/xz...ar#summary
Global Femtosecond Lasers for Cataract Surgery Market Report 2013 to 2018
M2 - Fri Nov 29, 3:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/m7w994/femtosecond) has announced the addition of a new report "Global Femtosecond Lasers for Cataract Surgery Market Report 2013 to 2018" to their offering. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need surgery. All older people develop cataracts, femtosecond lasers for cataract surgery improve the quality of the surgery in a dramatic manner. Femtosecond laser technology for cataract surgery represents a paradigm shift. Surgeons approach cataract surgery with the ability to use automated process that is more reliable and more repeatable than manual techniques previously available. Key Topics Covered: Executive Summary 1. Femtosecond Lasers for Cataract Surgery 2. Femtosecond Lasers for Cataract Surgery 3. Cataract Surgery Femtosecond: Laser Product Description 3.1 Alcon Surgical LenSx? Laser 3.2 Bausch Lomb and Technolas Perfect Vision 3.3 Abbott Medical Optics 3.4 Carl Zeiss VisuMax 3.5 MEL 80 Excimer Laser 4. Femtosecond Lasers for Cataract Surgery Technology 4.1 Opportunity To Further Improve The Outcomes Of Cataract Surgery 4.2 Femtosecond Laser Application To Cataract Surgery Innovation 4.3 Abbott Femtosecond Laser Garners FDA Clearance For Cataract Surgery 4.4 LensAR Laser Cataract Surgery System 4.5 Cataract Incision 4.6 Astigmatism Correction at the Time of Cataract Surgery 4.7 FDA Status of Laser Cataract Surgery Systems in the United States 4.8 Cataract Surgery Most Common Surgical Procedure 4.9 Advantages of Calmar Fiber Lasers 4.10 The Human Eye 4.11 Cataracts 4.12 Intraocular Tens Technology 4.13 Refractive Disorders 4.14 Studies On The Restor Toric Lens 4.15 Surgeons Need To Concentrate On Proper Patient Selection 4.16 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses 5. Femtosecond Laser for Cataract: Surgery Company Description Companies Mentioned - AISIN / IMRA Femtolite F / H - Abbott - Bioptigen - Biovision - Calmar Laser - Family - Market Participants - Novartis / Alcon - Novartis / Alcon - Ophtec Artisan R - OptiMedica - Raydiance 5-60 - Staar Surgical 5-66 - Valeant / Bausch & Lomb - WaveTec Vision - Zeiss For more information visit http://www.researchandmarkets.com/research/m7...emtosecond
STAAR Surgical To Present At Piper Jaffray Healthcare Investor Conference
PR Newswire - Thu Nov 21, 11:19AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry Caldwell, President and CEO, and Steve Brown, CFO, will participate in a fireside chat at the 25th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel on Tuesday, December 3 at 3:00 p.m. ET.
Global Ophthalmology Drugs And Devices (Diagnostic & Surgical) Market Report 2013-2017
M2 - Thu Nov 21, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/384qp6/ophthalmology) has announced the addition of the "Global Ophthalmology Drugs And Devices (Diagnostic & Surgical) Market Report 2013-2017" report to their offering. The ophthalmology drugs and devices market is divided into four major segments, namely, surgical devices, diagnostic and monitoring devices, vision care, and drugs. The devices market is divided into applications like surgery and diagnostics. Drugs market is classified into existing treatment drugs and drugs in pipeline and the vision care market is segmented into spectacles and contact lenses. The total market is forecasted till 2017. This market is also considered by formulation types such as capsules, gels, eye drops, ointment, and eye solutions. Advancements in technologies, high prevalence rates of refractive error, cataract, and glaucoma, increasing demand for the diagnostic procedures and low compliance with pharmaceuticals will propel the devices market. However, lack of awareness of diseases like glaucoma hinders the growth of this market. The drugs market will grow at a slower pace mainly due to the combined effect of loss of patent protection for several drugs and drying pipeline. The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (RoW). North America is the largest market for ophthalmology drugs and devices, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace, primarily due to the economic slowdown and saturation in these markets. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Ophthalmology Devices Market 5 Global Ophthalmology Drug Market 6 Geographic Analysis 7 Competitive Landscape 8 Company Profiles Companies Mentioned - Abbott Laboratories - Alcon, Inc. - Allergan, Inc - Bausch & Lomb, Inc. - Carl Zeiss Meditec Ag - Ellex Medical Lasers Limited - Essilor International S.A - Hoya Corporation - Iridex Corporation - Johnson & Johnson - Merck & Co., Inc - Nidek Co., Limited - Novagali Pharma S.A - Novartis Ag - Pfizer, Inc - Roche Holding Ag - Santen Pharmaceutical Co., Ltd. - Staar Surgical Company - Topcon Corporation - Ziemer Group Holding Ag For more information visit http://www.researchandmarkets.com/research/38...thalmology
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
IPOs and Transactions: February 24 - 28
PR Newswire - Tue Mar 04, 10:35AM CST
There were 45 transactions filed with the SEC last week.
Visian® ICL(TM) with CentraFLOW® Approved to Market in Japan
PR Newswire - Mon Mar 03, 8:14AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Visian Implantable Collamer Lens with CentraFLOW technology, which is driven by the KS-AquaPORT, has been approved by the Japanese Ministry of Health, Labor and Welfare. With this approval, the range of treatment has been expanded for Visian ICL product offering to include not only the CentraFLOW technology, but also expands the treatment of myopic down to -3.0 diopters as compared to the current range which starts at -5.0 diopters.
STAAR Surgical Reports 15% Fourth Quarter Revenue Growth and 13% Full Year 2013
PR Newswire - Wed Feb 26, 3:01PM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported revenue for the fourth quarter ended January 3, 2014 of $18.9 million, a 15% increase over $16.5 million reported for the fourth quarter of 2012. The effect of foreign currency exchange reduced sales by $1.1 million during the quarter. On a constant currency basis, revenues grew 22% during the fourth quarter of 2013 compared to the fourth quarter of 2012. The results included record quarterly sales of $11.5 million of the Company's Visian® ICL product portfolio and $6.6 million of its IOL products. Low margin Other Product sales were $812,000, a 12% decrease over the prior year and a 3% decrease in constant currency.
Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 25, 5:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/qppn9j/contact_lens) has announced the addition of the "Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Contact Lens Market (Gas Permeable Contact Lens and Soft Contact Lens) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' Contact lens are medical devices that offer convenience, confidence and self-esteem to the people who need vision correction. Factors such as rising ophthalmic disorders, vision problem and changing lifestyle accentuates the uptake of contact lenses during the forecast period. In addition, therapeutic, aesthetic and cosmetic are the major reasons driving the growth of contact lens market globally. The market for contact lens is segmented as by characteristics (gas-permeable and soft contact lens), by design (spherical, toric, soft, multifocal, cosmetic and orthokeratology contact lens) and by usage (corrective, therapeutic, post-operative, cosmetic, enhancement, opaque and special effect, prosthetic, computer, D-segment, sports and custom-made). The report includes market estimations of the global contact lens market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contact lens market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019. The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the contact lens market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Contact Lens Market, by Characteristics Chapter 5 Contact Lens Market, by Design Chapter 6 Contact Lens Market, by Usage Chapter 7 Contact Lens Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles List of Figures List of Tables Companies Mentioned - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/qp...ntact_lens About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
STAAR Surgical To Present At The 34th Annual Cowen Health Care Conference
PR Newswire - Mon Feb 24, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 34th Annual Cowen Health Care Conference at the Boston Marriott Copley Place Hotel on Monday, March 3 at 4:50 p.m. ET.
STAAR Surgical Announces Fourth Quarter 2013 Results Release Date, Conference Call And Webcast
PR Newswire - Fri Feb 14, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release its financial results for the fourth quarter ended January 3, 2014 on Wednesday, February 26, 2014 after the market close.
ReneSola Supplies Several Million Watts of Solar PV to Chevron
PR Newswire - Fri Feb 14, 3:00AM CST
ReneSola Ltd ("ReneSola") (NYSE: SOL), a leading brand and technology provider of solar photovoltaic ("PV") products, announced today that it provided 10,000 of its high efficiency solar PV modules to Chevron Energy Solutions, one of the largest installers of solar power in the United States, for a 3.1MW multi-site project in Lemoore, California. The multi-array project will consist of 2.85MW of ReneSola's 72-cell 300W polycrystalline modules and 260KW of 260W monocrystalline modules.
VMS Ventures Announces Annual Meeting, Record Date and Adopts Advance Notice Policy
Marketwire Canada - Thu Feb 13, 9:31AM CST
VMS Ventures Inc. (TSX VENTURE:VMS) ("VMS Ventures" or the "Company") announced on February 13, 2014 that it will hold an annual meeting of shareholders (the "Meeting") on April 17, 2014. The record date for the shareholders entitled to vote at the Meeting has been set as shareholders of record as at the close of business on March 10, 2014.
FDA Postpones Meeting To Review Staar Surgical's TICL Submission Due To Weather
PR Newswire - Thu Feb 13, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported the U.S. Food & Drug Administration's Ophthalmic Devices Panel of the Medical Devices Advisory Committee meeting scheduled for Friday, February 14, 2014 has been postponed due to weather. The Agency has assured the Company that it intends to reschedule the meeting as soon as practically possible. The meeting was being convened by the Agency to ask the Panel questions regarding STAAR's PMA supplement submission seeking approval to market the Company's Visian Toric Implantable Collamer® Lens. Any rescheduled date will be published by the FDA on its website.
Concise Analysis of the International Femtosecond Lasers for Cataract Surgery Market - Forecasts to 2018
M2 - Fri Jan 31, 4:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/p7nkbl/femtosecond) has announced the addition of a new report "Concise Analysis of the International Femtosecond Lasers for Cataract Surgery Market - Forecasts to 2018" to their offering. This femtosecond laser cataract surgical system equipment makes it possible to deliver reproducible, predictable, and improved clinical outcomes for cataract surgery. Through image-guided visualization and micron-level laser precision, the surgeon has complete control over the surgery process. Femtosecond laser cataract surgical systems offer an improved patient safety profile. Because of the simultaneous change in demographics and the introduction of automated process, ophthalmologists are facing an explosion in demand for their services the next 20 years. The aging of the baby boomers and the fact that patients older than 65 consume 10 times the eye care of patients younger than 65 creates unprecedented demand for cataract surgery. Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting. Cataract surgical technology is evolving rapidly. Laser-assisted cataract surgery technology is gaining traction with clinicians. Surgeons are getting trained in the techniques needed to perform surgeries using these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision. Key Topics Covered: Femtosecond Lasers for Cataract Surgery: Executive Summary 1. Femtosecond Lasers for Cataract Surgery: Market Shares and Market Forecasts 2. Femtosecond Lasers for Cataract Surgery 3. Cataract Surgery Femtosecond 4. Femtosecond Lasers for Cataract Surgery Technology 5. Femtosecond Laser for Cataract Companies Mentioned: - AISIN / IMRA Femtolite F / H - Abbott - Bioptigen - Biovision - Calmar Laser - Family - Market Participants - Novartis / Alcon - Novartis / Alcon - Ophtec Artisan R - OptiMedica - Raydiance 5-60 - Staar Surgical 5-66 - Valeant / Bausch & Lomb - WaveTec Vision - Zeiss For more information visit http://www.researchandmarkets.com/research/p7...emtosecond
Align Technology Announces ClinCheck(R) Pro With Interactive 3D Controls
Marketwire - Thu Jan 30, 3:00PM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced the upcoming release of ClinCheck Pro, the next generation Invisalign treatment software tool, designed to provide more precise control over final tooth position and to help Invisalign providers achieve their treatment goals.
Kathryn Tunstall Appointed To STAAR Surgical Board Of Directors
PR Newswire - Thu Jan 30, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the appointment of Kathryn Tunstall to its Board of Directors. Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a developer, maker, and marketer of medical devices for women. In 2013 Conceptus was acquired by Bayer AG for $1.1 billion. Her appointment expands the number of directors to seven.
STAAR Surgical Company (STAA) Jumps: Stock Up 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 8:39AM CST
STAAR Surgical Company was a big mover last session, as its shares rose almost 6% on the day.
2013 Report on the International Surgical Ophthalmology Market
M2 - Fri Dec 13, 3:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/t7rpn5/global_markets) has announced the addition of the "2013 Report on the International Surgical Ophthalmology Market" report to their offering. Refractive surgeries will also contribute to revenue growth, although economic headwinds in key national markets will limit the performance of these procedures. Other key trends, including pricing in local markets and product mix, will have key effects on competitive shares and product adoption. Key Topics Covered: 1. EXECUTIVE SUMMARY 1.1 The Global Market by Region 1.2 The Global Market by Product Segment 2. OVERVIEW 2.1 Anatomy of the Human Eye 2.2 Blindness and Low Vision 2.3 Cataract Surgery 2.4 Glaucoma Surgery 2.5 Vitreoretinal Surgery 2.6 Refractive Surgery 3. OPHTHALMIC DIAGNOSTIC DEVICES 3.1 Slit Lamps 3.2 Ocular Tonometers 3.3 Corneal Pachymeters 3.4 Optical Coherence Tomography 3.5 Optical Biometers 3.6 Scanning Laser Polarimeters 3.7 Fundus Cameras 3.8 Wavefront Aberrometers 4. OPHTHALMIC SURGICAL SYSTEMS 4.1 Phacoemulsification Systems 4.2 Ophthalmic Laser Systems 5. IMPLANTS AND DISPOSABLES 5.1 Intraocular Lenses 5.2 Glaucoma Implants 6. PROCEDURE VOLUMES AND MARKET FORECASTS 6.1 Global Procedure Volumes 6.2 Global Market Analysis 6.3 Competitive Analysis 6.4 Regional Analysis 7. COMPANY PROFILES Companies Mentioned: - Abbott Medical Optics - Accutome - Alcon - Bausch & Lomb - Carl Zeiss Meditec - Dutch Ophthalmic Research Center (DORC) International BV - Ellex - Haag-Streit AG - Iridex Corporation - LensAR - Lumenis Vision - Nidek Company, Ltd. - Oertli Instruments AG - Ophtec BV - Optimedica - Quantel Medical - Staar Surgical - Technolas Perfect Vision - Topcon Medical Systems - Ziemer Ophthalmic Systems AG For more information visit http://www.researchandmarkets.com/research/t7...al_markets
STAAR Surgical Up 97.6% Since SmarTrend Uptrend Call (STAA)
Comtex SmarTrend(R) - Mon Dec 02, 9:09AM CST
SmarTrend identified an Uptrend for STAAR Surgical (NASDAQ:STAA) on January 2nd, 2013 at $6.33. In approximately 11 months, STAAR Surgical has returned 97.63% as of today's recent price of $12.51.
2013 Report on the International Intraocular Lenses Market
M2 - Fri Nov 29, 4:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/xz96c5/intraocular#summary) has announced the addition of the "2013 Report on the International Intraocular Lenses Market" report to their offering. Despite initial lethargy in adoption by surgeons, intraocular lens (IOL) implants are today standard treatment of care for cataract. Cataract surgeries using IOLs are currently one of the most common and safest surgical procedures carried out worldwide. With the rise in aging population and increase in the incidence of ophthalmic and ocular conditions, vision care represents a growing sector of the medical industry. Among the ocular diseases, cataract is the most common cause of blindness, followed by glaucoma, AMD and DR. The IOL market is also benefiting from the development of premium intraocular lenses, adoption of which is driven by factors such as superior visual outcomes, and long term safety, efficacy, and rotational stability. While improved access to superior medical technologies drives growth in developing countries, the continued shift towards premium IOLs including toric, accommodative and multifocal IOLs, is fuelling demand in developed countries. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview 3. Trends & Issues 4. Competition 5. Product Landscape 6. Product Overview 7. Effects Of Intraocular Lenses Implantations 8. Regulations Governing The Production And Approval Of Iols 9. Product Approvals/Introductions 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 36 (including Divisions/Subsidiaries - 48) - The United States (20) - Canada (1) - Japan (6) - Europe (14) - France (3) - Germany (5) - The United Kingdom (1) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (7) Companies Mentioned - Abbott Medical Optics - Bausch & Lomb - Carl Zeiss - Eyekon Medical - Humanoptics - Lenstec - Morcher GmbH - Novartis AG - Oculentis BV - Ophtec BV - Ophtec USA - Physio SA - PowerVision - Rayner Intraocular Lenses - Santen Pharmaceutical - Advanced Vision Science - Staar Surgical Company - Suzhou Medical Apparatus and Instrument - Tekia - US IOL - Wavelight AG For more information visit http://www.researchandmarkets.com/research/xz...ar#summary
Global Femtosecond Lasers for Cataract Surgery Market Report 2013 to 2018
M2 - Fri Nov 29, 3:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/m7w994/femtosecond) has announced the addition of a new report "Global Femtosecond Lasers for Cataract Surgery Market Report 2013 to 2018" to their offering. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need surgery. All older people develop cataracts, femtosecond lasers for cataract surgery improve the quality of the surgery in a dramatic manner. Femtosecond laser technology for cataract surgery represents a paradigm shift. Surgeons approach cataract surgery with the ability to use automated process that is more reliable and more repeatable than manual techniques previously available. Key Topics Covered: Executive Summary 1. Femtosecond Lasers for Cataract Surgery 2. Femtosecond Lasers for Cataract Surgery 3. Cataract Surgery Femtosecond: Laser Product Description 3.1 Alcon Surgical LenSx? Laser 3.2 Bausch Lomb and Technolas Perfect Vision 3.3 Abbott Medical Optics 3.4 Carl Zeiss VisuMax 3.5 MEL 80 Excimer Laser 4. Femtosecond Lasers for Cataract Surgery Technology 4.1 Opportunity To Further Improve The Outcomes Of Cataract Surgery 4.2 Femtosecond Laser Application To Cataract Surgery Innovation 4.3 Abbott Femtosecond Laser Garners FDA Clearance For Cataract Surgery 4.4 LensAR Laser Cataract Surgery System 4.5 Cataract Incision 4.6 Astigmatism Correction at the Time of Cataract Surgery 4.7 FDA Status of Laser Cataract Surgery Systems in the United States 4.8 Cataract Surgery Most Common Surgical Procedure 4.9 Advantages of Calmar Fiber Lasers 4.10 The Human Eye 4.11 Cataracts 4.12 Intraocular Tens Technology 4.13 Refractive Disorders 4.14 Studies On The Restor Toric Lens 4.15 Surgeons Need To Concentrate On Proper Patient Selection 4.16 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses 5. Femtosecond Laser for Cataract: Surgery Company Description Companies Mentioned - AISIN / IMRA Femtolite F / H - Abbott - Bioptigen - Biovision - Calmar Laser - Family - Market Participants - Novartis / Alcon - Novartis / Alcon - Ophtec Artisan R - OptiMedica - Raydiance 5-60 - Staar Surgical 5-66 - Valeant / Bausch & Lomb - WaveTec Vision - Zeiss For more information visit http://www.researchandmarkets.com/research/m7...emtosecond
STAAR Surgical To Present At Piper Jaffray Healthcare Investor Conference
PR Newswire - Thu Nov 21, 11:19AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry Caldwell, President and CEO, and Steve Brown, CFO, will participate in a fireside chat at the 25th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel on Tuesday, December 3 at 3:00 p.m. ET.
Global Ophthalmology Drugs And Devices (Diagnostic & Surgical) Market Report 2013-2017
M2 - Thu Nov 21, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/384qp6/ophthalmology) has announced the addition of the "Global Ophthalmology Drugs And Devices (Diagnostic & Surgical) Market Report 2013-2017" report to their offering. The ophthalmology drugs and devices market is divided into four major segments, namely, surgical devices, diagnostic and monitoring devices, vision care, and drugs. The devices market is divided into applications like surgery and diagnostics. Drugs market is classified into existing treatment drugs and drugs in pipeline and the vision care market is segmented into spectacles and contact lenses. The total market is forecasted till 2017. This market is also considered by formulation types such as capsules, gels, eye drops, ointment, and eye solutions. Advancements in technologies, high prevalence rates of refractive error, cataract, and glaucoma, increasing demand for the diagnostic procedures and low compliance with pharmaceuticals will propel the devices market. However, lack of awareness of diseases like glaucoma hinders the growth of this market. The drugs market will grow at a slower pace mainly due to the combined effect of loss of patent protection for several drugs and drying pipeline. The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (RoW). North America is the largest market for ophthalmology drugs and devices, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace, primarily due to the economic slowdown and saturation in these markets. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Ophthalmology Devices Market 5 Global Ophthalmology Drug Market 6 Geographic Analysis 7 Competitive Landscape 8 Company Profiles Companies Mentioned - Abbott Laboratories - Alcon, Inc. - Allergan, Inc - Bausch & Lomb, Inc. - Carl Zeiss Meditec Ag - Ellex Medical Lasers Limited - Essilor International S.A - Hoya Corporation - Iridex Corporation - Johnson & Johnson - Merck & Co., Inc - Nidek Co., Limited - Novagali Pharma S.A - Novartis Ag - Pfizer, Inc - Roche Holding Ag - Santen Pharmaceutical Co., Ltd. - Staar Surgical Company - Topcon Corporation - Ziemer Group Holding Ag For more information visit http://www.researchandmarkets.com/research/38...thalmology
(0)
(0)STAAR Surgical Company (STAA) Stock Research Links
Scroll down for more posts ▼